CMS clears Cigna to resume selling prescription Medicare plans

CMS lifted sanctions on Bloomfield, Conn.-based Cigna restricting the payer from marketing and enrolling members in its Medicare Advantage prescription drug and Medicare Part D plans, according to a June 16 Securities and Exchange Commission filing.

CMS sanctioned Cigna Jan. 21, 2016, after an audit found the payer failed to comply with CMS' Medicare Part C and Part D requirements. As a result, members experienced delays or denials in medical services and prescription drugs. CMS' audit also revealed the deficiencies increased out-of-pocket expenses for some policyholders.

CMS' clearance means Cigna can resume selling its Medicare prescription drug plans immediately, with coverage beginning July 1.  

More articles on payer issues:
Cleveland Clinic, Oscar Health to offer co-branded health plan
Centene to enter ACA exchanges in 3 states
BCBS of Louisiana names CMO
 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Top 40 articles from the past 6 months